R. Don Elsey
2019 - Lyra Therapeutics
In 2019, R. Don Elsey earned a total compensation of $737.8K as Chief Financial Officer at Lyra Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $41,671 |
|---|---|
| Option Awards | $501,247 |
| Salary | $130,625 |
| Other | $64,235 |
| Total | $737,778 |
Elsey received $501.2K in option awards, accounting for 68% of the total pay in 2019.
Elsey also received $41.7K in non-equity incentive plan, $130.6K in salary and $64.2K in other compensation.
Rankings
In 2019, R. Don Elsey's compensation ranked 10,522nd out of 13,971 executives tracked by ExecPay. In other words, Elsey earned more than 24.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,522 out of 13,971 | 25th |
Division Manufacturing | 4,254 out of 5,701 | 25th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 568 out of 832 | 32nd |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 354 out of 535 | 34th |
Industry Surgical and Medical Instruments and Apparatus | 232 out of 350 | 34th |
Source: SEC filing on April 14, 2021.
Elsey's colleagues
We found one more compensation record of an executive who worked with R. Don Elsey at Lyra Therapeutics in 2019.
2019
Maria Palasis
Lyra Therapeutics